Faculty & Research Interests


Maria A. Sorbera, Pharm.D., AAHIVP, BCACP
Assistant Professor of Pharmacy Practice
Division of Pharmacy Practice
718-488-1000 x1982


Pharm.D., LIU Pharmacy

Short Biography

Dr. Sorbera received her PharmD degree from Long Island University. She completed a Post Graduate Year-1 Residency at the NY Harbor VA Healthcare system where she developed an interest in ambulatory care. This interest led her to complete a Post Graduate Year-2 Ambulatory Care Residency at The Brooklyn Hospital Center. Before joining LIU Pharmacy, she practiced in academia for approximately two years. She is an assistant professor of Pharmacy Practice with her practice at The Brookdale Hospital and Medical Center. She provides outpatient/inpatient services for HIV primary care, HCV co-infection, anticoagulation and pharmacotherapy. In addition, she precepts APPE pharmacy students and pharmacy residents.

Dr. Sorbera is board certified in ambulatory care and certified as an HIV pharmacist. She is also certified to practice collaborative drug therapy management in New York.

Research Synopsis
HIV/AIDS and Hepatitis C: Involved in evaluating the management of patients living with HIV/Hepatitis C and their comorbidities.
Pharmacy Practice in Ambulatory Care Settings: Evaluating the impact clinical pharmacists have on patient care in improving individual and public health outcomes.
Selected Publications

  • Sorbera M, Mathew C, Christy Ramdeen S. Implementation of a Hepatitis C Collaborative Drug Therapy Management Service in an HIV Ambulatory Care Clinic. INNOVATIONS in pharmacy. January 2018;9(1):Article 6.
  • Sorbera M, Joseph T., DiGregorio R. Elevated International Normalized Ratio in a Patient Taking Warfarin and Mauby: A Case Report. J Pharm Pract. 2016. Aug 19.
  • Del Bello D, Cha A, Sorbera M, et al. Real-world Sustained Virologic Response Rates of Sofosbuvir-containing Regimens in Patients Coinfected with Hepatitis C and HIV. Clin Infect Dis. 2016 March 1.
  • Sorbera MA, Friedman ML, Cope R. “New and Emerging Evidence on the Use of SecondGeneration Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment.” J Pharm Pract. 2016 Feb 22. [Epub ahead of print].
  • Sorbera M, Chung E, Ho CW, Marzella N. “Ceftolozane/Tazobactam: A New Option in the Treatment of Complicated Gram-Negative Infections”, Pharmacy and Therapeutics. 2014 Dec; 39(12): 825, 828-832.


LIU Pharmacy
Arash T. Dabestani